© 2002 by European Society of Cardiology
OPINION
Implantable devices to treat atrial fibrillation: real prospects or just new gimmicks?
Département de Cardiologie & Maladies Vasculaires, Centre Cardio-Pneumologique Hôpital Pontchaillou/CHU, 35033, Rennes, Cedex, France
Key Words: Atrial fibrillation, AV junctional ablation, ventricular pacing, atrial pacing, algorithms for AF control, implantable cardioverter defibrillators
References
[1] Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. Circulation 1998; 98: 953–960.
[2] Rodriguez LM, Smeets RM, Baiyan X, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993; 72: 1137–1141.[CrossRef][Web of Science][Medline]
[3] Edner M, Caidahl K, Bergfelt L, et al. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995; 74: 261–267.
[4] Levy T, Walker S, Mason M, et al. Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomized controlled study. Heart 2001; 85: 171–178.
[5] Oczan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001; 344: 1043–1051.
[6] Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995; 92: 1954–1968.
[7] Andersen HR, Thesen L, Bagger JM, Vesterlund T, Bloch-Thomsen PR. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997; 350: 1210–1216.[CrossRef][Web of Science][Medline]
[8] Lamas GA, Orav JE, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338: 1097–1104.
[9] Lamas GA, Lee K, Sweeney M, et al. The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale and baseline characteristics of the first 1000 patients. Am Heart J 2000; 140: 451–551.[CrossRef][Web of Science][Medline]
[10] Padeletti L, Porciani MC, Michelucci A, et al. Interatrial septal pacing: A new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol 1999; 3: 35–43.[CrossRef][Web of Science][Medline]
[11] Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachman's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12: 912–917.[CrossRef][Web of Science][Medline]
[12] Mabo P, Paul V, Jung W, Clémenty J, Bouhour A, Daubert C. Biatrial synchronous pacing for atrial arrhythmias prevention: the SYNBIAPACE study. Eur Heart J 1999; 20: 4.
[13] Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual site atrial pacing and antiarrhythmic drug therapy. Eur Heart J 2001; 22: 553.
[14] Carlson MD, Gold MR, Ip J, et al. Dynamic overdrive pacing decreases symptomatic atrial arrhythmia burden in patients with sinus node dysfunction. Circulation 2001; 104: II-383.
[15] Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation. The Atrial Pacing Peri-Ablation for Paroxysmal Atrial Fibrillation (PA3) study. Circulation 2000; 102: 121–130.
[16] Adler SW, Wolpert C, Warman EN, Musley SK, Kochler JL, Euler DE. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001; 104: 887–892.
[17] Wellens HJJ, Lau CP, Lüderitz B, et al. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 1998; 98: 1651–1656.
[18] Friedman PA, Dijkman B, Warman EN, et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001; 104: 1023–1028.
[19] The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. Atrial fibrillation follow-up investigation of rhythm management-the AFFIRM study design. Am J Cardiol 1997; 79: 1198–1202.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||